| Michael Joseph Mulligan, MD | |
|
701 E El Camino Real, Mountain View, CA 94040-2833 | |
| (650) 934-7888 | |
| Not Available |
| Full Name | Michael Joseph Mulligan |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 38 Years |
| Location | 701 E El Camino Real, Mountain View, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306884283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | G62916 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three-dimensional structures in large volumes and at costs that won't bankrupt health care systems.
New cervical cancer screening guidelines are the latest example of this emerging cautious view.
A new test for cervical cancer was found to detect all of the cancers in a randomized clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus test at a reduced cost, according to a study led by Queen Mary University of London.
MEDTOX Scientific, Inc. today announced results for the third quarter ended September 30, 2010. MEDTOX achieved record revenues and gross profit in the quarter.
› Verified 5 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three-dimensional structures in large volumes and at costs that won't bankrupt health care systems.
New cervical cancer screening guidelines are the latest example of this emerging cautious view.
A new test for cervical cancer was found to detect all of the cancers in a randomized clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus test at a reduced cost, according to a study led by Queen Mary University of London.
MEDTOX Scientific, Inc. today announced results for the third quarter ended September 30, 2010. MEDTOX achieved record revenues and gross profit in the quarter.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Joseph Mulligan, MD 2350 W El Camino Real, 2nd Floor, Mountain View, CA 94040-6201 Ph: () - | Michael Joseph Mulligan, MD 701 E El Camino Real, Mountain View, CA 94040-2833 Ph: (650) 934-7888 |
News Archive
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three-dimensional structures in large volumes and at costs that won't bankrupt health care systems.
New cervical cancer screening guidelines are the latest example of this emerging cautious view.
A new test for cervical cancer was found to detect all of the cancers in a randomized clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus test at a reduced cost, according to a study led by Queen Mary University of London.
MEDTOX Scientific, Inc. today announced results for the third quarter ended September 30, 2010. MEDTOX achieved record revenues and gross profit in the quarter.
› Verified 5 days ago
Julia A Cronin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7888 Fax: 650-934-7895 | |
Dr. Steven Rubinstein, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 701 E El Camino Real, Medical Staff Office, Mountain View, CA 94040 Phone: 650-934-7888 | |
Jamila C. Martin, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7888 | |
Dr. Philippe Begin, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2500 Grant Rd, Safar, Packard At El Camino Hospital, Mountain View, CA 94040 Phone: 650-561-2876 | |
Dr. Patty Peng-jung Chi, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7888 | |
Meng Chen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2500 Grant Rd Fl 4, Mountain View, CA 94040 Phone: 650-521-7237 |